These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22996214)

  • 21. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.
    Gil Cuesta J; Aavitsland P; Englund H; Gudlaugsson Ó; Hauge SH; Lyytikäinen O; Sigmundsdóttir G; Tegnell A; Virtanen M; ; Krause TG
    Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27123691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic.
    Reed C; Katz JM; Hancock K; Balish A; Fry AM;
    PLoS One; 2012; 7(10):e48187. PubMed ID: 23118949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal trends of influenza A (H1N1) virus seroprevalence following 2009 pandemic wave in Guangdong, China: three cross-sectional serology surveys.
    Yang F; He J; Zhong H; Ke C; Zhang X; Hong T; Ni H; Lin J
    PLoS One; 2012; 7(6):e38768. PubMed ID: 22719938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.
    Tacken MA; Jansen B; Mulder J; Visscher S; Heijnen ML; Campbell SM; Braspenning JC
    Vaccine; 2013 Jan; 31(6):900-5. PubMed ID: 23246546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort study.
    Li M; Wang W; Chen J; Zhan Z; Xu M; Liu N; Ren L; You L; Zheng W; Shi H; Zhao Z; Huang C; Chen X; Zheng N; Lu W; Zhou X; Zhou J; Liao Q; Yang J; Jit M; Salje H; Yu H
    Lancet Microbe; 2023 Nov; 4(11):e893-e902. PubMed ID: 37827184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008-2010.
    Sam IC; Shaw R; Chan YF; Hooi PS; Hurt AC; Barr IG
    J Med Virol; 2013 Aug; 85(8):1420-5. PubMed ID: 23765779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.
    Subelj V; Prosenc K; Sočan M
    Wien Klin Wochenschr; 2012 Mar; 124(5-6):177-80. PubMed ID: 22327938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.
    Hoschler K; Thompson C; Andrews N; Galiano M; Pebody R; Ellis J; Stanford E; Baguelin M; Miller E; Zambon M
    Emerg Infect Dis; 2012 Nov; 18(11):1894-7. PubMed ID: 23092684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.
    Mörner A; Bråve A; Kling AM; Kühlmann-Berenzon S; Krook K; Hedenskog M; Silhammar I; Ljungman M; Ortqvist A; Andersson S; Brytting M; Thorstensson R; Linde A
    PLoS One; 2012; 7(12):e53511. PubMed ID: 23285299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross-Sectional Study From 2014 to 2019.
    Guiomar R; Pereira da Silva S; Costa I; Conde P; Cristóvão P; Rodrigues AP; Fernandes A; Dias AP; Couto AR; Ramos A; Moita C; Rodrigues C; Vale F; Caldeira F; Bruges Armas J; Pereira-Vaz J; Alves J; Freitas L; Martins L; Milho L; Mota-Vieira L; Lopes L; Freitas M; Pessanha MA; Correia M; Marques MH; Cardoso MJ; Peres MJ; Cunha M; Amantegui P; Mota P; Lopes P; Pereira P; Viseu R; Cabral R; Côrte-Real R; Almeida S; Soares V; Mansinho K; Hungnes O; Nunes B
    Influenza Other Respir Viruses; 2024 May; 18(5):e13307. PubMed ID: 38798072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.
    Maltezou HC; Katerelos P; Mavrouli M; Lourida A; Routsias JG; Spanakis N; Maragos A; Tedoma A; Bassiakos Y; Koratzanis G; Mantagos S; Metallidis S; Katragkou A; Nikolaidis P; Roilides E; Theodoridou M; Tsakris A
    Vaccine; 2011 Sep; 29(38):6664-9. PubMed ID: 21762749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.
    Kumar S; Fan J; Melzer-Lange M; Trost J; Havens PL; Willoughby RE; Chusid MJ; Henrickson KJ
    Pediatr Emerg Care; 2011 Sep; 27(9):804-7. PubMed ID: 21878831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against avian-like A (H1N1) swine influenza virus among swine farm residents in eastern China.
    Yin X; Yin X; Rao B; Xie C; Zhang P; Qi X; Wei P; Liu H
    J Med Virol; 2014 Apr; 86(4):592-6. PubMed ID: 24497077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study.
    Kang EK; Eun BW; Kim NH; Lim JS; Lee JA; Kim DH
    BMC Infect Dis; 2016 Aug; 16(1):438. PubMed ID: 27549626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.